Vitamin B12 status, cognitive decline and dementia: A systematic review of prospective cohort studies

British Journal of Nutrition

Volumn 108, Issue 11, 2012, Pages 1948-1961

  O'Leary, Fiona ^a   Allman Farinelli, Margaret ^a   Samman, Samir ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cognition; Dementia; Systematic reviews; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; METHYLMALONIC ACID; TRANSCOBALAMIN; BIOLOGICAL MARKER;

ADULT; AGED; AMNESIA; CLINICAL PROTOCOL; COGNITIVE DEFECT; COHORT ANALYSIS; DATA EXTRACTION; DEMENTIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; QUALITY CONTROL; QUALITY OF LIFE; RELIABILITY; REVIEW; SCREENING TEST; STROOP TEST; SYSTEMATIC REVIEW; VALIDITY; BLOOD; COGNITION; CYANOCOBALAMIN DEFICIENCY; DISEASE COURSE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NUTRITIONAL STATUS; PATHOPHYSIOLOGY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COGNITION; COGNITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; METHYLMALONIC ACID; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NUTRITIONAL STATUS; TRANSCOBALAMINS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 84871261162     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512004175     Document Type: Review

References (78)

1. Smith AD (2008) The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr Bull 29, S143-S172.
2. Camicioli R & Rockwood K (2010) Dementia diagnosis. In Brocklehurst's Textbook of Geriatric Medicine and Gerontology, 7th ed., pp. 385-391 [HM Fillit, K Rockwood and K Woodhouse, editors]. Amsterdam: Elsevier.
3. Corder EH & Beaumont H (2007) Susceptibility groups for Alzheimer's disease (OPTIMA cohort): integration of gene variants and biochemical factors. Mech Ageing Dev 128, 76-82.
4. 12 levels in senile dementia and confusional states. Geriatrics 14, 367-373.
5. Martin DC, Francis J, Protetch J, et al. (1992) Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 40, 168-172.
6. 12 deficiency and dementia. Int Psychogeriatr 7, 85-88.
7. Healton EB, Savage DG, Brust JC, et al. (1991) Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 70, 229-245.
8. 12 deficiency among demented patients and cognitive recovery with cobalamin replacement. J Nutr Health Aging 6, 254-260.
9. Nilsson K, Gustafson L & Hultberg B (2001) Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 16, 609-614.
10. 12 deficiency in elderly dementia patients and control subjects. J Geriatr Psychiatry Neurol 18, 33-38.
11. 12, folic acid, and the nervous system. Lancet Neurol 5, 949-960.
12. Morrison LD, Smith DD & Kish SJ (1996) Brain S-adenosyl-methionine levels are severely decreased in Alzheimer's disease. J Neurochem 67, 1328-1331.
13. McCracken C, Hudson P, Ellis R, et al. (2006) Methylmalonic acid and cognitive function in the Medical Research Council Cognitive Function and Ageing Study. Am J Clin Nutr 84, 1406-1411.
14. Wald DS, Kasturiratne A & Simmonds M (2011) Serum homo-cysteine and dementia: meta-analysis of eight cohort studies including 8669 participants. Alzheimer's dement 7, 412-417.
15. Werder SF (2010) Cobalamin deficiency, hyperhomocystei-nemia, and dementia. Neuropsychiatr Dis Treat 6, 159-195.
16. Van Dam F & Van Gool WA (2009) Hyperhomocysteinemia and Alzheimer's disease: a systematic review. Arch Gerontol Geriatr 48, 425-430.
17. Ellinson M, Thomas J & Patterson A (2004) A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet 17, 371-383 (quiz 85-7).
18. Ho RCM, Cheung MWL, Fu E, et al. (2011) Is high homo-cysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression. Am J Geriatr Psychiatry 19, 607-617.
19. Balk E, Chung M, Raman G, et al. (2006) Vitamins and Berries and Age-related Neurodegenerative Disorders. Evidence Report/Technology Assessment no. 134, AHRQ Publication no. 06-E008. Rockville, MD: Agency for Healthcare Research and Quality.
20. 12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract 63, 1061-1067.
21. Raman G, Tatsioni A, Chung M, et al. (2007) Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function. J Nutr 137, 1789-1794.
22. 12 on cognitive function in adults and the elderly. Food Nutr Bull 29, S132-S142.
23. Liberati A, Altman DG, Tetzlaff J, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62, e1-e34.
24. American Dietetic Association (2012) Evidence Analysis Manual: Steps in the Evidence Analysis Process. http://www.adaevidencelibrary.com/topic.cfm? cat¼1155 (accessed January 2012).
25. National Institute for Health and Clinical Excellence (2009) The Guidelines Manual. http://www.nice.org.uk/aboutnice/howwework/ developingniceclinicalguidelines/clinicalguide linedevelopmentmethods/ GuidelinesManual2009.jsp? domedia¼1&mid¼5F238D80-19B9- E0B5-D4CB1191544B5D45 (accessed March 2010).
26. Clarke R, Birks J, Nexo E, et al. (2007) Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr 86, 1384-1391.
27. 12 and folate insufficiency and cognitive decline. Neurology 72, 361-367.
28. Hooshmand B, Solomon A, Kareholt I, et al. (2010) Homo-cysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology 75, 1408-1414.
29. Kivipelto M, Annerbo S, Hultdin J, et al. (2009) Homocys-teine and holo-transcobalamin and the risk of dementia and Alzheimer's disease: a prospective study. Eur J Neurol 16, 808-813.
30. 12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 42, 933-936.
31. Wang HX, Wahlin A, Basun H, et al. (2001) Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology 56, 1188-1194.
32. Ravaglia G, Forti P, Maioli F, et al. (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82, 636-643.
33. Annerbo S, Wahlund L & Lökk J (2005) The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients. Dement Geriatr Cogn Disord 20, 209-214.
34. Annerbo S, Wahlund L & Lökk J (2006) The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment: a 6-year follow-up study. Am J Alzheimers Dis Other Demen 21, 182-188.
35. 12/folate status of elderly Europeans. J Nutr Health Aging 6, 43-50.
36. Huang CW, Chang WN, Lui CC, et al. (2010) Impacts of hyper- homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up. Curr Alzheimer Res 7, 527-533.
37. La Rue A, Koehler KM, Wayne SJ, et al. (1997) Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr 65, 20-29.
38. Tu MC, Huang CW, Chen NC, et al. (2010) Hyperhomocystei-nemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period. Acta Neurol 19, 168-177.
39. Kim J-M, Kim S-W, Shin I-S, et al. (2008) Folate, vitamin b(12), and homocysteine as risk factors for cognitive decline in the elderly. Psychiatry Investig 5, 36-40.
40. Haan MN, Miller JW, Aiello AE, et al. (2007) Homocysteine B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 85, 511-517.
41. Kado DM, Karlamangla AS, Huang M-H, et al. (2005) Homo-cysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 118, 161-167.
42. Elias MF, Sullivan LM, D'Agostino RB, et al. (2005) Homo-cysteine and cognitive performance in the Framingham offspring study: age is important. Am J Epidemiol 162, 644-653.
43. Teunissen CE, Blom AHJ, Van Boxtel MPJ, et al. (2003) Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J Nutr Health Aging 7, 153-159.
44. McCaddon A, Hudson P, Davies G, et al. (2001) Homo-cysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 12, 309-313.
45. van den Kommer TN, Dik MG, Comijs HC, et al. (2010) Homocysteine and inflammation: predictors of cognitive decline in older persons? Neurobiol Aging 31, 1700-1709.
46. 12, and cognitive function and decline. Epidemiology 17, 650-657.
47. Tucker KL, Qiao N, Scott T, et al. (2005) High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 82, 627-635.
48. Mooijaart SP, Gussekloo J, Frolich M, et al. (2005) Homocys-teine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am J Clin Nutr 82, 866-871.
49. Nurk E, Refsum H, Tell GS, et al. (2005) Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Ann Neurol 58, 847-857.
50. Garcia A, Haron Y, Pulman K, et al. (2004) Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. J Gerontol A Biol Sci Med Sci 59, 1323-1327.
51. Dufouil C, Alperovitch A, Ducros V, et al. (2003) Homo-cysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 53, 214-221.
52. Zylberstein DE, Lissner L, Bjorkelund C, et al. (2011) Midlife homocysteine and late-life dementia in women. A prospective population study. Neurobiol Aging 32, 380-386.
53. 12 and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiatry 79, 864-868.
54. Seshadri S, Beiser A, Selhub J, et al. (2002) Plasma homocys-teine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346, 476-483.
55. Luchsinger JA, Tang MX, Shea S, et al. (2004) Plasma homo-cysteine levels and risk of Alzheimer disease. Neurology 62, 1972-1976.
56. Bowirrat A, Friedland RP, Farrer L, et al. (2002) Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. J Mol Neurosci 19, 239-245.
57. Oulhaj A, Refsum H, Beaumont H, et al. (2010) Homo-cysteine as a predictor of cognitive decline in Alzheimer's disease. Int J Geriatr Psychiatry 25, 82-90.
58. Small BJ & Backman L (1998) Predictors of longitudinal changes in memory, visuospatial, and verbal functioning in very old demented adults. Dement Geriatr Cogn Disord 9, 258-266.
59. Small BJ, Viitanen M, Winblad B, et al. (1997) Cognitive changes in very old persons with dementia: the influence of demographic, psychometric, and biological variables. J Clin Exp Neuropsychol 19, 245-260.
60. Ravaglia G, Forti P, Maioli F, et al. (2006) Conversion of mild cognitive impairment to dementia. Predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord 21, 51-58.
61. 12 in health and disease. Nutrients 2, 299-316.
62. Green R (2011) Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. Am J Clin Nutr 94, 666S-672S.
63. Willis CD, Elshaug AG, Milverton JL, et al. (2011) Diagnostic performance of serum cobalamin tests: a systematic review and meta-analysis. Pathology 43, 472-481.
64. Hooshmand B, Solomon A, Kareholt I, et al. (2012) Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study. J Intern Med 271, 204-212.
65. Folstein MF, Folstein SE & McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
66. Schafer JH, Glass TA, Bolla KI, et al. (2005) Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc 53, 381-388.
67. Smith A, Smith SM, de Jager CA, et al. (2010) Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One 5, 1-10.
68. Vogiatzoglou A, Refsum H, Johnston C, et al. (2008) Vitamin B-12 status and rate of brain volume loss in community-dwelling elderly. Neurology 71, 826-832.
69. 12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry 80, 149-157.
70. Payton A (2009) The impact of genetic research on our understanding of normal cognitive ageing: 1995 to 2009. Neuropsychol Rev 19, 451-477.
71. Raber J, Huang Y & Ashford JW (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25, 641-650.
72. 12 or folate among adults aged 75 years and older. Neuropsychology 18, 362-370.
73. Bunce D, Kivipelto M & Wahlin A (2005) Apolipoprotein E, B vitamins, and cognitive function in older adults. J Gerontol: Series B: Psychol Sci Soc Sci 60, P41-P48.
74. Brown B, Huang MH, Karlamangla A, et al. (2011) Do the effects of APOE-epsilon4 on cognitive function and decline depend upon vitamin status? MacArthur Studies of Successful Aging. J Nutr Health Aging 15, 196-201.
75. 12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. Proc Natl Acad Sci U S A 104, 19995-20000.
76. Morris MS, Jacques PF, Rosenberg IH, et al. (2007) Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 85, 193-200.
77. Smith AD, Kim Y-I & Refsum H (2008) Is folic acid good for everyone? Am J Clin Nutr 87, 517-533.
78. Carmel R, Green R, Rosenblatt DS, et al. (2003) Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program 62-81.